Human Molecular Genetics, 2001, Vol. 10, No. 19 2099-2107
© 2001 Oxford University Press
Frataxin expression rescues mitochondrial dysfunctions in FRDA cells
Department of Molecular Biosciences and 1Department of Nutrition, University of California, Davis, CA 95616, USA and 2Division of Biochemistry and Genetics, Istituto Nazionale Neurologico Carlo Besta, Milan, Italy
Friedreich’s ataxia (FRDA) is the result of mutations in the nuclear-encoded frataxin gene, which is expressed in mitochondria. Several lines of evidence have suggested that frataxin is involved in mitochondrial iron homeostasis. We have transfected the frataxin gene into lymphoblasts of FRDA compound heterozygotes (FRDA-CH) with deficient frataxin expression to produce FRDA-CH-t cells in which message and protein are rescued to near-physiological levels. FRDA-CH cells were more sensitive to oxidative stress by challenge with free iron, hydrogen peroxide and the combination, consistent with a Fenton chemical mechanism of pathophysiology, and this sensitivity was rescued to control levels in FRDA-CH-t cells. Iron challenge caused increased mitochondrial iron levels in FRDA-CH cells, and a decreased mitochondrial membrane potential (MMP), both of which were rescued in FRDA-CH-t cells. The rescue of the low MMP, and high mitochondrial iron concentration by frataxin overexpression suggests that these cellular phenotypes are relevant to the central pathophysiological process in FRDA which is aggravated by exposure to free iron. However, even at physiological iron concentrations, FRDA-CH cells had decreased MMP as well as lower activities of aconitase and ICDH (two enzymes supporting MMP), and twice the level of filtrable mitochondrial iron (but no increase in total mitochondrial iron), and the observed phenotypes were either fully or partially rescued in FRDA-CH-t cells. Free iron is known to be toxic. The observation that frataxin deficiency (either directly or indirectly) causes an increase in filtrable mitochondrial iron provides a new hypothesis for the mechanism of cell death in this disease, and could be a target for therapy.
+ To whom correspondence should be addressed. Tel: +1 530 754 9665; Fax: +1 530 754 9342; Email: gacortopassi@ucdavis.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. R. Anderson, K. Kirby, W. C. Orr, A. J. Hilliker, and J. P. Phillips Hydrogen peroxide scavenging rescues frataxin deficiency in a Drosophila model of Friedreich's ataxia PNAS, January 15, 2008; 105(2): 611 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Condo, N. Ventura, F. Malisan, A. Rufini, B. Tomassini, and R. Testi In vivo maturation of human frataxin Hum. Mol. Genet., July 1, 2007; 16(13): 1534 - 1540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Shan, E. Napoli, and G. Cortopassi Mitochondrial frataxin interacts with ISD11 of the NFS1/ISCU complex and multiple mitochondrial chaperones Hum. Mol. Genet., April 15, 2007; 16(8): 929 - 941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Condo, N. Ventura, F. Malisan, B. Tomassini, and R. Testi A Pool of Extramitochondrial Frataxin That Promotes Cell Survival J. Biol. Chem., June 16, 2006; 281(24): 16750 - 16756. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J R Porter and T G Barrett Monogenic syndromes of abnormal glucose homeostasis: clinical review and relevance to the understanding of the pathology of insulin resistance and {beta} cell failure J. Med. Genet., December 1, 2005; 42(12): 893 - 902. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. R. Anderson, K. Kirby, A. J. Hilliker, and J. P. Phillips RNAi-mediated suppression of the mitochondrial iron chaperone, frataxin, in Drosophila Hum. Mol. Genet., November 15, 2005; 14(22): 3397 - 3405. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Everett and N. W. Wood Trinucleotide repeats and neurodegenerative disease Brain, November 1, 2004; 127(11): 2385 - 2405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Campanella, G. Isaya, H. A. O'Neill, P. Santambrogio, A. Cozzi, P. Arosio, and S. Levi The expression of human mitochondrial ferritin rescues respiratory function in frataxin-deficient yeast Hum. Mol. Genet., October 1, 2004; 13(19): 2279 - 2288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Seznec, D. Simon, L. Monassier, P. Criqui-Filipe, A. Gansmuller, P. Rustin, M. Koenig, and H. Puccio Idebenone delays the onset of cardiac functional alteration without correction of Fe-S enzymes deficit in a mouse model for Friedreich ataxia Hum. Mol. Genet., May 15, 2004; 13(10): 1017 - 1024. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. Alldredge, C. R. Schlieve, N. R. Miller, and L. A. Levin Pathophysiology of the Optic Neuropathy Associated With Friedreich Ataxia Arch Ophthalmol, November 1, 2003; 121(11): 1582 - 1585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Tan, E. Napoli, F. Taroni, and G. Cortopassi Decreased expression of genes involved in sulfur amino acid metabolism in frataxin-deficient cells Hum. Mol. Genet., July 15, 2003; 12(14): 1699 - 1711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Pianese, L. Busino, I. De Biase, T. de Cristofaro, M. S. Lo Casale, P. Giuliano, A. Monticelli, M. Turano, C. Criscuolo, A. Filla, et al. Up-regulation of c-Jun N-terminal kinase pathway in Friedreich's ataxia cells Hum. Mol. Genet., November 1, 2002; 11(23): 2989 - 2996. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Corsi, A. Cozzi, P. Arosio, J. Drysdale, P. Santambrogio, A. Campanella, G. Biasiotto, A. Albertini, and S. Levi Human Mitochondrial Ferritin Expressed in HeLa Cells Incorporates Iron and Affects Cellular Iron Metabolism J. Biol. Chem., June 14, 2002; 277(25): 22430 - 22437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Shoichet, A. T. Baumer, D. Stamenkovic, H. Sauer, A. F. H. Pfeiffer, C. R. Kahn, D. Muller-Wieland, C. Richter, and M. Ristow Frataxin promotes antioxidant defense in a thiol-dependent manner resulting in diminished malignant transformation in vitro Hum. Mol. Genet., April 1, 2002; 11(7): 815 - 821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Cavadini, H. A. O'Neill, O. Benada, and G. Isaya Assembly and iron-binding properties of human frataxin, the protein deficient in Friedreich ataxia Hum. Mol. Genet., February 1, 2002; 11(3): 217 - 227. [Abstract] [Full Text] [PDF]
|
|